PRIMARY DOCUMENT

Company

Solid Biosciences Inc.

Filed

December 12, 2022

Accession Number

0001654954-22-016350

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →